Profil
David McMullin served as the Chief Commercial Officer at Aldeyra Therapeutics, Inc. from 2019 to 2021.
Prior to that, he was the Group Vice President-U.S.
Internal Medicine at Shire Plc from 2015 to 2017, and the VP-Global Supply Chain Operations & Strategy at Novartis Vaccines & Diagnostics, Inc. from 2010 to 2015.
McMullin received his undergraduate degree from Brigham Young University and his MBA from Harvard Business School.
Ehemalige bekannte Positionen von David McMullin
| Unternehmen | Position | Ende |
|---|---|---|
| ALDEYRA THERAPEUTICS, INC. | Corporate Officer/Principal | 01.01.2021 |
| SHIRE | Corporate Officer/Principal | 01.05.2017 |
Novartis Vaccines & Diagnostics, Inc.
Novartis Vaccines & Diagnostics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Corporate Officer/Principal | 01.03.2015 |
Ausbildung von David McMullin
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Aldeyra Therapeutics, Inc.
Aldeyra Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for eye diseases | Health Technology |
Shire Plc
Shire Plc Pharmaceuticals: MajorHealth Technology Develops and markets medicines for patients with rare diseases | Health Technology |
Brigham Young University
Brigham Young University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Vaccines & Diagnostics, Inc.
Novartis Vaccines & Diagnostics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Harvard Business School
Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















